09-Feb-2012 - AMPAC Fine Chemicals posted a 50 per cent jump in revenues after the return of sales from its antiviral business.
08-Feb-2012 - Pharma supply chain consortium Rx-360 has advised drugmakers to check their L-Arginine stocks, warning that a recent surge in demand could limit supplies.
08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.
08-Feb-2012 - GSK is developing tablets it can compress without excipients to cut the time taken to reach the clinic by up to nine months.
07-Feb-2012 - Shanghai Pharmaceuticals has bought a 70 per cent stake in ingredients developer and manufacturer Changzhou Kony Pharm in a bid to boost its standing in the API market.
07-Feb-2012 - Australia is considering steps to stop chemicals used in drug manufacturing from being diverted by terrorists to make explosives.
06-Feb-2012 - The Indian Drug Manufacturers Association (IDMA) plans to amp up pharma business in Tamil Nadu by helping more companies meet WHO production standards.
06-Feb-2012 - Johnson Matthey says sales of an anti-addiction API were the key to gains made by its fine chemicals business in Q3.
06-Feb-2012 - A US drug shortages act aims to make drug production more efficient by quickening review of post-approval manufacturing changes.
02-Feb-2012 - European Commission plans to add three APIs to its list of water polluting chemicals could result in costs to pharmaceutical companies.
01-Feb-2012 - Food ingredients and flavours firm Kerry Group is to build a cell culture and media development lab for the pharmaceutical biomanufacuturing sector.
31-Jan-2012 - DSM Pharmaceutical Products (DPP) will sell APIs made by Indian manufacturer Indoco Remedies in a new agreement that fits with its global expansion plan.
31-Jan-2012 - Ingredient maker Dishman Pharmaceuticals has confirmed that it may offload its Chinese API (active pharmaceutical ingredients) factory.
30-Jan-2012 - BASF has hiked its prices for ethanolamines just days after asking the European Commission to review measures designed to stop US exporters selling the compound at less than cost to manufacturers in Europe.
26-Jan-2012 - in-PharmaTechnologist presents a round-up of issues within the pharmaceutical manufacturing industry, including Novartis’ plans to restart Nebraska ops and problems for Roche at it’s South Carolina facility.
26-Jan-2012 - Europe is considering forcing API manufacturers to verify the source of starting materials as part of GMP revisions.
25-Jan-2012 - Ibuprofen API maker Albemarle says favourable volumes and pricing helped drive gains made by fine chemicals unit in Q4.
25-Jan-2012 - Ashland is investing in production assets and raising prices as it looks to get the most from its $3.2bn acquisition.
24-Jan-2012 - Granules India says Big Pharma demand for highly efficient manufacturing in era of patent loss helped it gain market share in Q3 fiscal 2012.
23-Jan-2012 - The EMA has revised guidelines on active substance master files (ASMF) to stop multiple EU nations assessing the same documents.
18-Jan-2012 - Enzymicals and Herbrand PharmaChemicals have partnered to incorporate biocatalytic processes into fine chemical manufacturing.
18-Jan-2012 - Sigma-Aldrich is prioritising HPAPIs as it seeks to grow its custom pharma business in the face of low-cost competition.
17-Jan-2012 - Excipient makers could save up to 200 man hours with a new industry-driven, third-party audit certification scheme set to launch next week.
17-Jan-2012 - The US FDA plans to study foreign regulators’ GMP inspection reports with a view to using them to support its enforcement efforts.
16-Jan-2012 - The US FDA has sent its generic user fee recommendations to Congress ahead of a meeting to discuss the plan next month.